Standout Papers

Efficacy and safety of belimumab i... 1985 2026 1998 2012 1.4k
  1. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial (2011)
    Sandra Navarra, Renato Guzmán et al. The Lancet
  2. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial (2008)
    Paul Emery, Ferdinand C. Breedveld et al. The Lancet
  3. Tofacitinib versus Methotrexate in Rheumatoid Arthritis (2014)
    Eun Bong Lee, Roy Fleischmann et al. New England Journal of Medicine
  4. Takayasu arteritis. A study of 32 North American patients. (1985)
    Stephen Hall, Walter G. Barr et al. PubMed
  5. Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study (2008)
    Edward Keystone, Mark C. Genovese et al. Annals of the Rheumatic Diseases
  6. Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis (2017)
    Philip J. Mease, Stephen Hall et al. New England Journal of Medicine
  7. Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis (2013)
    Joel M. Kremer, Zhanguo Li et al. Annals of Internal Medicine
  8. Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor (2014)
    Arthur Kavanaugh, Philip J. Mease et al. Annals of the Rheumatic Diseases
  9. Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial (2018)
    Mark C. Genovese, Roy Fleischmann et al. The Lancet

Immediate Impact

11 from Science/Nature 113 standout
Sub-graph 1 of 18

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Interferon- γ and infectious diseases: Lessons and prospects
2024 StandoutScience
3 intermediate papers

Works of Stephen Hall being referenced

Tofacitinib versus Methotrexate in Rheumatoid Arthritis
2014 Standout
Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis
2013 Standout
and 3 more

Author Peers

Author Last Decade Papers Cites
Stephen Hall 6088 2442 3051 141 8.8k
Laurent Arnaud 3520 652 2098 264 8.1k
Olivier Meyer 4275 762 1631 236 7.4k
Guido Reber 5731 4007 1665 115 9.6k
Jacques Morel 2583 878 1727 216 5.7k
Ian Mackie 2150 4282 1852 228 9.4k
Ming‐Hui Zhao 3467 934 4676 535 12.9k
Zhanguo Li 2138 721 2008 354 6.0k
Alfons A den Broeder 3426 947 1222 222 4.8k
Annamaria Iagnocco 5650 1630 800 257 8.2k
Sunil Agarwal 1516 653 787 173 7.8k

All Works

Loading papers...

Rankless by CCL
2026